Commentary|Podcasts|August 5, 2024
Empty Shelves, Urgent Solutions
Author(s)Miranda Schmalfuhs
Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts, alternative solutions to ensure continued access to medications for all Americans, potential long term consequences if these pharmacy closures continue, and more
Advertisement
Michael Abrams, Managing Partner at Numerof & Associates discusses:
- Pharmacy deserts
- The main factors that are contributing to the closures of both large and independent pharmacies
- Alternative solutions can help ensure continued access to medications for all Americans (particularly those in underserved communities)
- Potential long term consequences if closures continue
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
2
GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications
3
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
4
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
5